Qvar
(Beclomethasone)ApprovedSmall molecule
Chiesi Farmaceutici S.p.A.Beclomethasone is an inhaled or nasal corticosteroid used to prevent and treat asthma symptoms and reduce nasal inflammation from allergies or nasal polyps.[2] Qvar is currently approved and in use across 8 indications[4].[1]
Qvar is one of 153 small molecule programs targeting Allergy. It is currently in Approved.
8
Indications
23
Total Trials
1
Active Trials
152
Competitors
Pipeline
Status by Indication[4][1]
Indication
Competition
Competitive Landscape
1050 competitors in Asthma
#DrugCompanyPhaseTrials
1Qvar
Chiesi Farmaceutici S.p.A.Approved
Formoterol Fumarate
AstraZenecaPreclinical
Symbicort
AstraZenecaPreclinical
Aciphex
Akero TherapeuticsPreclinical
Decadron
QQuince Therapeutics S.p.A.
Preclinical
Solu-Medrol
MMassachusetts Eye and Ear Infirmary
Preclinical
Aclidinium Bromide
AstraZenecaPreclinical
Lexapro
SShirley Ryan AbilityLab
Preclinical
Spiriva
Boehringer IngelheimPreclinical
Fasenra
AstraZenecaPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Asthma8 trials
Show 5 more trials
Treatment2 trials
Directed Topical Drug Delivery for Treatment for PASC Hyposmia
Completed·—·Phase 2·NCT05970731·16 enrolled
Wheezing2 trials
Gene Expression2 trials
8 more indications
Dyspnea1 trial
THL1 trial
Beclomethasone in Healthy Athletes
Unknown status·—·Phase 4·NCT05352191·30 enrolled
Vitiligo1 trial
Betamethasone Phonophoresis For Vitiligo
Recruiting·—·N/A·NCT07267273·60 enrolled
Sore Throat1 trial
Sources
References
- [1]
- [2]MedlinePlus Drug Information — Qvar drug information. U.S. National Library of Medicine, National Institutes of Health.
- [3]
- [4]Open Targets Platform — Drug–disease associations for Beclomethasone. EMBL-EBI & Wellcome Sanger Institute.
- [5]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[3]
- Highest Phase
- Approved[1]
- Company